Construction of Osmotic Pressure Responsive Vacuole-like Bacterial Organelles with Capsular Polysaccharides as Building Blocks

Biomolecular Condensate-Based Artificial Organelle for Driving Compartmentalized Flux Control

Microbial cell factories have emerged as versatile bioreactors capable of orchestrating complex metabolic networks to convert renewable feedstocks into high-value biochemicals. Nevertheless, the diffusion-mediated dispersion of metabolic intermediates often compromises biosynthesis efficiency, primarily attributable to the absence of artificial subcellular compartments for spatiotemporal organization of catalytic enzymes. Herein, we established a synthetic biology platform leveraging engineered biomolecular condensates to achieve precise flux control via a modular pathway compartmentalization. First, the fused sarcoma low complexity domain (FUSLCD) was designed to combine the GCN4 to rationally integrate with GCN4 scaffold proteins to create programmable artificial organelles. Second, the protein recruitment and assembly functions of artificial organelles were identified by a short peptide pair or directly fusing with the FUSLCD protein in a spatial organization way. Third, using the 2'-fucosyllactose (2'-FL) de novo biosynthesis pathway as a model system, we demonstrated enhanced pathway efficiency by colocalizing critical enzymes within artificial organelles in engineered E. coli, yielding a significant improvement in 2'-FL titer through flux compartmentalization. This study not only overcome diffusion-limited reactions via engineered spatial organization but also offer a versatile toolkit for optimizing compartmentalized biosynthesis pathways.

Parabens alter the surface characteristics and antibiotic susceptibility of drinking water bacteria

Parabens are markedly present in products of daily use, considered emerging environmental contaminants that can harm human health and aquatic life, due to their release into aquatic sources. The impact of the exposure of microbial communities to parabens remains unclear. This study investigates aspects of the mode of action of methylparaben (MP), propylparaben (PP), butylparaben (BP), and MIX at environmental (15 μg/L) and in-use (15000 μg/L) concentrations, against two bacterial strains of Acinetobacter calcoaceticus and Stenotrophomonas maltophilia previously isolated from drinking water (DW). BP showed the strongest antimicrobial activity, while MP exhibited the weakest. The mechanism of action of parabens at the selected concentrations was found to be related to perturbations on physicochemical bacterial cell surface properties and charge, by causing an increase of bacterial cell envelope hydrophilicity and zeta potential values. In addition, parabens may activate osmotic regulation mechanisms as observed by the increase in vacuole area for MP-exposed A. calcoaceticus. The bacterial metabolic activity as well as bacterial size was also affected by parabens exposure. MP exposure further enhanced the biofilm formation ability and increased bacterial tolerance to antibiotics. The results raise environmental implications, particularly concerning water quality and public health, as parabens exposure can potentiate the virulence of DW bacteria, increasing the risk of human exposure to harmful microorganisms.

Coordinated optimization of the polymerization and transportation processes to enhance the yield of exopolysaccharide heparosan

Heparosan as the precursor for heparin biosynthesis has attracted intensive attention while Escherichia coli Nissle 1917 (EcN) has been applied as a chassis for heparosan biosynthesis. Here, after uncovering the pivotal role of KfiB in heparosan biosynthesis, we further demonstrate KfiB is involved in facilitating KpsT to translocate the nascent heparosan polysaccharide chain. As a result, an artificial expression cassette KfiACB was constructed with optimized RBS elements, resulting in 0.77 g/L heparosan in shake flask culture. Moreover, in view of the intracellular accumulation of heparosan, we further investigated the effects of overexpression of the ABC transport system proteins on heparosan biosynthesis. By co-overexpressing KfiACB with KpsTME, the heparosan production in flask cultures was increased to 1.03 g/L with an extracellular concentration of 0.96 g/L. Eventually, the engineered strain EcN/pET-kfiACB3-galU-kfiD-glmM/pCDF-kpsTME produced 12.2 g/L heparosan in 5-L fed-batch cultures while the extracellular heparosan was about 11.2 g/L. The results demonstrate the high-efficiency of the strategy for co-optimizing the polymerization and transportation for heparosan biosynthesis. Moreover, this strategy should be also available for enhancing the production of other polysaccharides.

Production of different molecular weight glycosaminoglycans with microbial cell factories

Glycosaminoglycans (GAGs) are naturally occurring acidic polysaccharides with wide applications in pharmaceuticals, cosmetics, and health foods. The diverse biological activities and physiological functions of GAGs are closely associated with their molecular weights and sulfation patterns. Except for the non-sulfated hyaluronan which can be synthesized naturally by group A Streptococcus, all the other GAGs such as heparin and chondroitin sulfate are mainly acquired from animal tissues. Microbial cell factories provide a more effective platform for the production of structurally homogeneous GAGs. Enhancing the production efficiency of polysaccharides, accurately regulating the GAGs molecular weight, and effectively controlling the sulfation degree of GAGs represent the major challenges of developing GAGs microbial cell factories. Several enzymatic, metabolic engineering, and synthetic biology strategies have been developed to tackle these obstacles and push forward the industrialization of biotechnologically produced GAGs. This review summarizes the recent advances in the construction of GAGs synthesis cell factories, regulation of GAG molecular weight, and modification of GAGs chains. Furthermore, the challenges and prospects for future research in this field are also discussed.

Designing Intracellular Compartments for Efficient Engineered Microbial Cell Factories

With the rapid development of synthetic biology, various kinds of microbial cell factories (MCFs) have been successfully constructed to produce high-value-added compounds. However, the complexity of metabolic regulation and pathway crosstalk always cause issues such as intermediate metabolite accumulation, byproduct generation, and metabolic burden in MCFs, resulting in low efficiencies and low yields of industrial biomanufacturing. Such issues could be solved by spatially rearranging the pathways using intracellular compartments. In this review, design strategies are summarized and discussed based on the types and characteristics of natural and artificial subcellular compartments. This review systematically presents information for the construction of efficient MCFs with intracellular compartments in terms of four aspects of design strategy goals: (1) improving local reactant concentration; (2) intercepting and isolating competing pathways; (3) providing specific reaction substances and environments; and (4) storing and accumulating products.